AU2003255130A1 - Inclusion compound of nateglinide - Google Patents
Inclusion compound of nateglinideInfo
- Publication number
- AU2003255130A1 AU2003255130A1 AU2003255130A AU2003255130A AU2003255130A1 AU 2003255130 A1 AU2003255130 A1 AU 2003255130A1 AU 2003255130 A AU2003255130 A AU 2003255130A AU 2003255130 A AU2003255130 A AU 2003255130A AU 2003255130 A1 AU2003255130 A1 AU 2003255130A1
- Authority
- AU
- Australia
- Prior art keywords
- nateglinide
- inclusion compound
- inclusion
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
- OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 title 1
- 229960000698 nateglinide Drugs 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN02132321.6 | 2002-08-27 | ||
| CNB021323216A CN1247194C (en) | 2002-08-27 | 2002-08-27 | Nagelinai clathrate compound |
| PCT/CN2003/000707 WO2004019989A1 (en) | 2002-08-27 | 2003-08-22 | Inclusion compound of nateglinide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003255130A1 true AU2003255130A1 (en) | 2004-03-19 |
Family
ID=31954573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003255130A Abandoned AU2003255130A1 (en) | 2002-08-27 | 2003-08-22 | Inclusion compound of nateglinide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1247194C (en) |
| AU (1) | AU2003255130A1 (en) |
| WO (1) | WO2004019989A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2912061A1 (en) * | 2007-02-01 | 2008-08-08 | Aliscience Soc Par Actions Sim | Cyclodextrin inclusion complexes of amino acids useful in pharmaceutical, veterinary, nutraceutical, food or cosmetic compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU718350B2 (en) * | 1996-11-15 | 2000-04-13 | Ajinomoto Co., Inc. | Tablet composition |
| ATE399000T1 (en) * | 1999-12-28 | 2008-07-15 | Ajinomoto Kk | ANTIDIABETES PREPARATION FOR ORAL ADMINISTRATION |
-
2002
- 2002-08-27 CN CNB021323216A patent/CN1247194C/en not_active Expired - Lifetime
-
2003
- 2003-08-22 AU AU2003255130A patent/AU2003255130A1/en not_active Abandoned
- 2003-08-22 WO PCT/CN2003/000707 patent/WO2004019989A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004019989A1 (en) | 2004-03-11 |
| CN1247194C (en) | 2006-03-29 |
| CN1478470A (en) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003266949A1 (en) | Compounds | |
| AU2003221098A1 (en) | Oligofluorenylene compounds | |
| AU2003236991A1 (en) | Representations of processes | |
| AU2003279366A1 (en) | Novel compounds | |
| AU2003245800A1 (en) | Flavourant compounds | |
| AU2003214112A1 (en) | Salts of nateglinide | |
| AU2003277596A1 (en) | Method of deuterization | |
| AU2003268687A1 (en) | Novel salt of 2-acylaminothiazole derivative | |
| AU2003216053A1 (en) | Guanidino compounds | |
| AU2003216859A1 (en) | Amidoacetonitrile compounds | |
| AU2003250858A1 (en) | Use of organic compounds | |
| AU2003215635A1 (en) | Thiazol-2-yl-imine compounds as pde-7 inhibitors | |
| AU2003253971A1 (en) | Polymorphic forms of nateglinide | |
| AUPS044102A0 (en) | New compound | |
| AU2002951868A0 (en) | Compound i | |
| AU2003298725A1 (en) | Preparation of metallotexaphyrins | |
| AU2003255130A1 (en) | Inclusion compound of nateglinide | |
| AU2003292667A1 (en) | Benzocycloheptapyridine compounds | |
| AU2003251259A1 (en) | Novel compounds | |
| AU2003238034A1 (en) | Novel use of imidazotriazinones | |
| AU2003299746A1 (en) | Total synthesis of daurichromenic acid | |
| AU2003275480A1 (en) | Compounds | |
| AU2003255322A1 (en) | Compounds | |
| AU2003240450A1 (en) | Manufacture of ketopantolactone | |
| AU2003217354A1 (en) | Synthesis of sulfamidates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |